Hetero Labs Limited - Unit IIIOctober 26, 2018

FDA 483 - Hetero Labs Limited - Unit III - October 26, 2018

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hetero Labs Limited - Unit III

Record Details

An FDA inspection of Hetero Labs, Ltd. - Unit III in Hyderabad, India, revealed significant deficiencies in their drug manufacturing processes. Observations included a lack of established control procedures to monitor output and validate manufacturing process performance, leading to inconsistent processes and failed batches. Additionally, master production and control records were found to be missing theoretical yield specifications.

Company: Hetero Labs Limited - Unit III
Inspection Date: October 26, 2018
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Yasamin Ameri (Compliance Officer)

Open in Dashboard

ID · 3adb6ed3-d4b8-482d-aecf-624f8ceb7aa5